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A Point-of-Care Device for Sensitive Protein
Quantification
Abstract—In this paper we present the design of a new point-
of-care (PoC) device for protein quantification. The proposed
design is based on a novel aptamer-mediated methodology and
real time polymerase chain reaction (RT-PCR), a robust and ul-
trasensitive method for DNA amplification, which we employ for
very sensitive quantification of proteins. In addition, we have also
developed an algorithm for the processing of raw fluorescence
data from the portable RT-PCR device. The algorithm leads to
better linearity than a proprietary software from a commercially
available RT-PCR machine. The modular nature of the system
allows for easy assembly and adjustedment towards a variety of
biomarkers for applications in disease diagnosis and personalised
medicine.
Index Terms—System design, point-of-care, RT-PCR, algo-
rithm, noise minimisation
I. INTRODUCTION
Point-of-care (PoC) tests refer to any diagnostic test done
near the patient, without the need for laboratory facilities
[1]. Most PoC devices for protein detection are based on the
enzyme-linked immunosorbent assay (ELISA), which requires
expensive equipment for detection and the use of a standard
curve for quantification, with limits of detection restricted by
the available equipment. An alternative approach could be
to use aptamers. Aptamers are short single-strand sequences
of DNA/RNA, and they offer many advantages compared to
antibodies, including long shelf life and simple workflow [2],
which make them particularly suitable for PoC devices. More-
over, being DNA sequences, they can be quantified through
real time polymerase chain reaction (RT-PCR) [3], a robust and
sensitive DNA quantification method which can theoretically
detect up to a few sequences. Previous studies [4]–[7] have
described portable and inexpensive RT-PCR machines, but did
not include automated sample preparation. Toumazou et al. [8]
proposed a device for automated sample preparation to be used
with a portable RT-PCR machine, but the device only applies
to DNA extraction and therefore, cannot directly be used for
protein quantification.
The work presented in this paper is part of our development
of an ultra-sensitive protein quantification system. Here we
propose a device which is portable, while addressing the issues
and challenges of implementation. The molecular methodol-
ogy is described in [9], whereas here we present the design
and technical aspects of our PoC device. The basis of our
approach is the amplification of a chemical signal through
the use of RT-PCR, which allows one to reliably detect very
small protein concentrations. The device description is based
on the quantification of the gut hormone leptin, an important
protein involved in the regulation of energy balance which is
associated to obesity and type 2 diabetes [10].
In principle, this technique can be used for very sensitive
and accurate PoC antigen testing, as well as antibody testing
for a variety of conditions, provided a suitable aptamer is
available and target-specific sequences are designed. Such a
device which would permit detection of very low levels of
antibodies, is very much sought after in the current COVID-
19 pandemic.
II. BACKGROUND
A. Aptamer-Adapter Complex methodology
The aptamer-based method for ultrasensitive protein quan-
tification is described in detail in [9]. A brief description is
presented in Fig. 1.
B. Aptamer-based PoC devices
Work by Dhiman et al. [11] extensively described the
applications of aptamer-based PoC devices, in which aptamers
are usually employed as a direct substitute of antibodies.
While most of the available PoC tests are inexpensive and
can be operated directly by the patient, they rely on visual
quantification which limits the sensitivity and resolution of
the tests. However, when aptamers are considered as DNA
sequences and PCR is used as the quantification method,
sensitivity and resolution can be greatly improved.
C. Techniques for analysis of RT-PCR data
PCR is a technique that works by doubling target DNA
sequences at each cycle until PCR resources (polymerase and
primers) are depleted and a plateau is reached. In RT-PCR,
fluorescence measurements are taken at each cycle, and a
sigmoidal curve is generated (Fig. 1(E)). The point at which
the fluorescence starts increasing significantly is called the
‘threshold cycle’ (Ct)–which is inversely proportional to the
DNA concentration–and is used to quantify samples against
a standard curve. This quantity is critical for quantifying the
original amount of the targeted substance; therefore, its precise
measurement is crucial.
There are numerous methods to obtain the Ct value, with
the simplest calculating the Ct value the cycle at which the
fluorescence signal crosses a constant threshold. Since this
Fig. 1: (A-D) Sensing methodology: chambers are pre-loaded with complexes (A); sample containing target protein is loaded and displaces the complexes
proportionally to its concentration (B); the master mix for complex elongation and PCR is loaded (C); the primers are loaded and PCR starts (D). (E) RT-PCR
sigmoid surves. (F) Temperature profile of the machine for sample preparation and RT-PCR.
Fig. 2: Functional block diagram of the proposed system.
method is sensitive to scale, it requires data scaling, usually
implemented through fitting to a logistic function [12]. Other
methods define the Ct as the cycle at which the 1st or 2nd
derivatives reach the maximum. More complicated algorithms
exist which achieve more precise estimates of Ct [13], [14]
but might be unsuitable for computation within a simple PoC
device.
III. POC SYSTEM DESIGN
The system implements the automated aptamer-based quan-
tification method described above and in [9]. As shown in Fig.
2, the system is composed of a sample preparation module
(actuators and cartridge, blue shadow), a thermocycler (fan,
heater and microcontroller, red shadow) to run the PCR, and
a sensing and data processing module (photodiodes array, LED
array, readout ciruit and processor, cyan shadow).
Below, we describe the design methodology for the cartridge
and the data processing of the RT-PCR data.
A. Cartridge
The cartridge implements the aptamer-based method and in
our case, it is using a leptin-specific aptamer, a complementary
adaptor and primers specific to the complexes. Given the
simplicity of this method that does not require discarding
solutions, a simple microfluidic cartridge operated by linear
actuators and air pumps can be implemented.
Fig. 3 shows the working principle of the cartridgde: upon
sample loading (in the chamber ‘Sample’ in Fig. 3), the
complexes (Fig. 3.1a) are displaced by leptin which attaches
to the aptamers (Fig. 3.1b). Then, the polymerase extends
the undisplaced complexes to form fully double stranded
sequences (Fig. 3.2). Finally during PCR the primers attach
specifically to the double stranded sequences without ampli-
fying free adaptors or aptamers (Fig. 3.3).
The sample, the standards and the control are loaded in
the chambers–pre-loaded with the hybridized aptamer-adaptor
complexes (‘Sample’ and control chambers, Fig. 3)–and in-
cubated at 37◦C for 30 minutes (Fig. 1B). The master mix
containing the polymerase and other PCR components is
loaded and the solutions are incubated at 60◦C for 30 minutes
(Fig. 1C). Right before the PCR starts, the primers are loaded
(Fig. 1D). The PCR happens in the same chambers array used
for sample preparation.
The two blister pouches containing the master mix and the
primer mix (Fig. 3) are operated by linear actuators, and air
pumps allow the solutions to flow. The main challenge con-
cerning the cartridge implementation is the design of suitable
mixing mechanisms to achieve a uniform distribution of the
Fig. 3: Microfluidic cartridge and underlying biochemical process.
molecules in the chambers, which ensures proper interaction
of the molecules. The shelf life of the master mix is a further
challenge; to avoid storage in freezers, the components should
be lyophilized and resuspended when running the samples.
This would require including extra pouches (and correspond-
ing actuators and pumps) containing the resuspension solution.
B. qPCR module
The RT-PCR module is based on the design a PCR unit
used for COVID-19 detection [15]. The module described in
this paper is made of heating and cooling elements acting
as a thermocycler for the cartridge, which is placed on an
aluminum heat block. Contrary to usual RT-PCR machines,
the present module includes a temperature profile for sample
preparation (incubation with sample and with master mix), see
Fig. 1(C), followed by pre-incubation at 95◦C for 600s and
a three-step PCR amplification: DNA denaturation 95◦C for
10s, primer annealing at 60◦C for 10s and DNA elongation
at 72◦C for 10s. At each annealing step, the LEDs shine blue
light of wavelength λ ≈ 497nm absorbed by the SYBR green
dye, which emits fluorescence in proportion to the target DNA
concentration in the chambers. The green light emitted by the
dye (λ ≈ 520nm) is captured by the photodiodes and readout
circuit.
The design of the RT-PCR machine affects the quantification
performance greatly: thermal cycling speed impacts DNA
amplification efficiency, and noise in the fluorescence detection
affects the precision of the measurements [16].
C. Data processing
The fluorescence data is likely to contain the noise in-
troduced during the biochemical process (due to mixing
Algorithm 1 Protein quantification algorithm MinFluo
1: procedure FIND CHAMBER NOISE(NoiseChambern)
2: for c = 1 to 10 do
3: NoiseChambern ← max(fn(c))
4: . For n = 0, ..., N chambers
5:
6: procedure FIND PEAK FLUORESCENCE(peakn)
7: . For n = 0, ..., N chambers
8: peakn = 0
9: while foundPeak = False do
10: for c = 11 to C do . C is total cycles
11: fn(c)clean ← fn(c)−NoiseChambern
12: fn(c)clean ← fn(c)−NoiseProcess(c)
13: . NoiseProcess(c) = f0(c)
14: if fn(c)clean < peakn−1 then
15: peakn ← fn(c)clean
16: else
17: foundPeak = True
18: procedure QUANTIFY SAMPLE(concsample)
19: m = peakc1−peakc2concc1−concc2




imperfections), during the PCR (due to device capabilities
and reaction efficiency), and during the fluorescence reading
(due to noise introduced by variations in photodiodes and
LED light intensity). Given the absence of washing steps, the
free sequences and proteins will remain in the chambers and
are likely to inhibit PCR. To minimise the effect of noise
introduced by the biochemical process (NoiseProcess), a
control is included and subtracted from the fluorescence of
the standards and samples.
The processing is done in real time while the PCR is
running–the processing algorithm is shown above. First, the
chamber noise NoiseChambern represents the noise of each
reaction and is determined as the maximum fluorescence in
the first 10 cycles. Then from cycle 11 at each cycle the
chamber noise is removed from all signals including the
control, and the process noise NoiseProcess is removed from
the standards and unknowns. Given the convex nature of the
cleaned fluorescence signal (see Fig. 4), the process stops once
the global minimum is found for each fluorescence signal, thus
reducing the RT-PCR running time.
Noise in the LED and photodiode variation can be min-
imised by splitting the final solutions with master mix and
primer mix in each chamber into replicated and considering
the average of the fluorescence across replicates.
IV. EXPERIMENTAL RESULTS
Fluorescence data was collected with a commercially avail-
able qPCR machine. Fig. 4 shows the fluorescence signals after
chamber and process noise removal, with the characteristic
peak. A standard curve was build by fitting a linear model to
the log(concentration) and the fluorescence at the minimum
Fig. 4: Fluorescence curves after chamber noise and process noise (control)
removal.
TABLE I: Comparison of R2 achieved by MinFluo (the method presented
in this paper) and by the processing done by a commercial software on three
different experiments.
Exp. 1 Exp. 2 Exp. 3
MinFluo 0.984 0.987 0.77
Commercial 0.384 0.973 0.53
(Fig 5b). Compared to the standard curve fitted on the Cts
estimated by the commercial software (Fig 5a), our method
MinFluo achieves better linearity. The same result is replicated
across multiple experiments (table I).
MinFluo improves linearity likely due to the removal of
the process noise represented by free adaptors, aptamers and
leptin left in the solution, which can interfere with the PCR.
By including a control, this process noise can be removed thus
improving the sample quantification.
Moreover, the MinFluo method allows for implementation
in real time and given its simplicity, it can be easily imple-
mented on a portable PoC device.
V. CONCLUSION
In this paper we have presented the design methodology of
a fully automated system for sensitive protein quantification
in a PoC setting. We described design considerations and
challenges associated to the implementation of the cartridge
for sample preparation and of the machine for RT-PCR.
Furthermore we presented preliminary results from the quan-
tification methodology followed by a simple data processing
algorithm for self-calibrated quantfication of the unknown
sample. This system can be used as a PoC device for protein
quantification, which has many applications ranging from
personalised healthcare for example through close monitoring
of hormonal changes, to disease diagnosis through detection
of protein biomarkers such as antibodies and receptors.
(a)
(b)
Fig. 5: Standard curves from leptin standards with the Ct method and without
noise removal (a), and with the minimum fluorescence method plus noise
removal (b).
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